Ullman Weighs in on DMAA Ruling

July 28, 2017 | Compliance Investigations & White Collar

Marc Ullman was quoted in Natural Products Insider’s article: “Hi-Tech Files Appeal in DMAA Fight with FDA,” which discusses Hi-Tech Pharmaceuticals Inc.’s quarrel with the federal government regarding the legality of the supplement DMAA, or 1,3-dimethylamylamine.

To read the article, click here.

Related News

Legal updates and news delivered to your inbox